Status:
UNKNOWN
Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
High-Grade Squamous Intraepithelial Lesions
Neoplasm Regression, Spontaneous
Eligibility:
FEMALE
18-50 years
Brief Summary
Consecutive inclusion and collection of information for all women attending the Cervical Disease Unit with an histological diagnosis of grade 2 or grade 3 CIN during the last 5 years, from January 201...
Detailed Description
Follow-up is performed every 4 months with colposcopy, cytology and biopsies. Colposcopy and cytology are performed for all control subjects. The need for biopsy is established according to the colpos...
Eligibility Criteria
Inclusion
- Reproductive age and willing to get pregnant in the future
- Acceptance of conservative management
- Commitment to study visits.
- Colposcopy with zone of transformation (ZT) type 1 or 2 (Unio esco-columnar totally visible) with image compatible with H-SIL and visible in its entirety.
Exclusion
- Pregnant women
- Immunosuppression for human immunodeficiency virus (HIV) or iatrogenic type
- suspicion or diagnosis of Glandular Cell Atipia (ACG), Adenocarcinoma in situ (AIS) or cervical cancer (CC)
- Provided that inclusion criteria are not met
Key Trial Info
Start Date :
October 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 28 2019
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04115787
Start Date
October 14 2019
End Date
December 28 2019
Last Update
October 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nerea Luqui Scarcelli
Barcelona, Spain, 08041